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Coordinated program between primary care and sleep unit
for the management of obstructive sleep apnea
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Gabriel Sampol3,8, Patricia Lloberes8, José Ignacio Aoiz 9, Joan Bayó9, Núria Grau10, Ana M. Fortuna1,3, Vicente Plaza1,3 and
M. Antònia Llauger3,11
The purpose of this study is to develop and validate a work model in the primary health-care setting for identifying patients with
obstructive sleep apnea–hypopnea syndrome (OSAHS) based on clinical variables and an ambulatory sleep monitoring study. After
screening, patients with mild–moderate OSAHS could be managed by primary care physicians, whereas those identified with severe
OSAHS would be referred to specialists from sleep units for starting specific treatment. The proposed model does not move the
entire health-care process to a generally overburdened primary care level and favors the coordinated work and the necessary
flexibility to adapt the model to challenges and perspectives of OSAHS.
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INTRODUCTION
Obstructive sleep apnea–hypopnea syndrome (OSAHS) is a
common breathing disorder in the general population,1 with
major clinical and socioeconomic consequences.2 OSAHS is
characterized by repetitive episodes of upper airway collapse
during sleep, resulting in cyclic decreases of arterial oxygen
saturation and transient cortical arousals, leading to non-
restorative sleep. Daytime sleepiness is a cardinal symptom of
OSAHS and if left untreated, it leads to cognitive dysfunction,
decrements in health-related quality of life, impaired work
performance, and increased risk for accidents in the workplace
and traffic accidents.3,4 Also, repetitive episodes of hypoxia and
enhanced sympathetic activity trigger pathogenic pathways
related to an increased risk for cardiovascular and metabolic
morbidity5–8 and mortality.9,10
Nasal continuous positive airway pressure (CPAP) during sleep is
the leading therapy for OSAHS.11 CPAP is highly effective in
controlling obstructive respiratory events, improvement of symp-
toms and quality of life of patients affected with OSHAS,12 and
significant reduction of blood pressure13,14 and insulin resis-
tance.15 Treatment with CPAP has been associated with a
decrease of all-cause and cardiovascular mortality.9
It has been estimated that the total cost of OSAHS would be
higher than that of other chronic diseases such as asthma and
chronic obstructive pulmonary disease (COPD) and similar to
diabetes-related expenses.16 A high percentage of OSAHS-related
costs are derived from societal consequences, including decreased
work productivity and the burden of road traffic accidents.17
OSAHS is clearly underdiagnosed, which is largely attributed to
oversaturation of sleep units where management of the disease
has been focused so far and where there are long lists of patients
waiting for diagnosis and treatment.18 Currently, there is
consensus that a disease with such relevant impact on the
individual’s health should involve all levels of care, with primary
care taking a more active role in the diagnosis and even
management of OSAHS.19,20 Different models of integral manage-
ment of patients with high clinical probability of OSAHS in the
primary care setting have been proposed, with non-inferior mid-
term results to those reported in sleep units.21–24 However,
although these results open new perspectives in management of
OSAHS, the feasibility of the implementation of these models in
clinical practice has been questioned. Among other limitations, it
has been argued that primary care physicians have to assume a
central role in the care of patients with OSAHS, which simplifies
excessively the management of patients with an increasingly
complex disease.25
AIMS
The PASHOS project (PASHOS is the Spanish acronym of
Advanced Platform for Sleep Apnea Syndrome Assessment) is
conceived with a different approach to the problem, that is, the
implementation of a comprehensive inter-level coordinated
program between primary care and specialist sleep centers for
patients with OSAHS. Advantages of the program include screen-
ing and tentatively management of OSAHS in the primary care
setting and prioritization of primary care referrals to specialized
care for starting CPAP treatment. The main objective is to develop
a simplified two-stage model for the management of patients with
OSAHS in the primary care setting based on a screening
questionnaire followed by an ambulatory sleep monitoring study
at home, and based on that information, a decision to refer to a
sleep unit or to manage them in the same primary care setting.
The secondary objectives are as follows: (1) to assess the validity of
management decisions made by primary care physicians (indica-
tion of CPAP versus no indication of CPAP), based on results of
clinical evaluation and ambulatory sleep study as compared to
therapeutic decisions made by specialists at the sleep unit; and (2)
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to analyze the cost-effectiveness of the coordinated strategy
versus the strategy that includes assessment of OSAHS solely in
the sleep unit.
DISCUSSION
This prospective and multicenter study protocol aims to validate a
coordinating work model between primary care and the sleep unit
for the management of OSAHS. The model includes training of
reference health-care professionals from primary care and
validation of simple screening tools that allow the family physician
to select the patients who can be managed in the primary care
setting (mild–moderate OSAHS) from those who have to be
referred to sleep units to start specific treatment. The study differs
from other interesting recent clinical trials22–24 in that it may be
applicable to the entire phenotypic spectrum of patients, because
inclusion is not restricted to a certain “a priori” clinical probability
of OSAHS, which accounts for only 30% of the total OSAHS
population.26,27 On the other hand, the model does not move the
entire health-care process to a generally overburdened primary
care level and favors the coordinated work and the necessary
flexibility to adapt the model to challenges and perspectives of
OSAHS.28,29
The exclusion of patients with moderate-to-severe COPD
deserves a comment. Patients with overlap syndrome (COPD/
OSAHS) present differential clinical characteristics than OSAHS
patients without COPD. In these patients, screening question-
naires (e.g., Epworth sleepiness scale, STOP-Bang sleep ques-
tionnaire) or other clinical parameters are not well predictors of
OSAHS, and it has been suggested that specific tools are necessary
to evaluate the risk of OSAHS in this population.30 Moreover, poor
sleep quality in patients with moderate-to-severe COPD may affect
the diagnostic reliability of the simplified ambulatory sleep study.
They also may present nocturnal hypoxemia due to multiple
mechanisms, besides upper airway occlusion characteristic of
OSAHS, such as ventilation/perfusion alterations or hypoventila-
tion. It is therefore a complex sleep respiratory disorder that
should be preferably studied with a full polysomnography.31
Limitations of the study include the upper age range of 75 years
as an inclusion criterion, so that it would be necessary to validate
the model in older age groups. Polysomnography was not used as
the standard diagnostic test for the diagnosis of OSA in adult
patients. Although respiratory polygraphy can underestimate the
diagnosis of OSA, we adapt our model to common available
resources in routine clinical practice and to recommendations of
guidelines suggesting the use of respiratory polygraphy only in
selected patients.32
In summary, we believe that results of this project could
represent a relevant change in the different levels of care for the




This is a prospective multicenter study that includes the participation of
sleep units from three tertiary care teaching hospitals in the urban area of
Barcelona (Spain), a sleep unit of a secondary care hospital (with capacity
to perform respiratory polygraphy studies and refer to a tertiary center if
polysomnography is needed), and six primary care teams of the reference
area of the four hospitals. The inclusion and exclusion criteria are shown in
Table 1.
This research has been already approved by the Clinical Research Ethics
Committee of the 10 participating centers. Written informed consent will
be obtained from all patients. The study has been registered at
ClinicalTrials.gov (identifier NCT02591979).
Training protocol
Prior to the beginning of the study, the following training program was
carried out:
Training of two reference professionals, one primary care physician, and
a nurse for each of the primary health-care centers participating in
the study.
Theoretical training (4 h) including updated information of definition
and epidemiology of OSAHS, clinical presentation and management of
specific questionnaires, clinical impact of the disease, diagnosis of
OSAHS, treatment and prevention, and aspects related to the care of
patients in the framework of the local health-care system.
Practical training for nursing (3 days, 6 h/day) including management of
home diagnostic equipment and interpretation of data, as well as basic
training in more complex sleep studies.
Training for primary care physicians (3 days, 6 h/day) including
indication and interpretation of the different diagnostic sleep studies
and clinical management of the patient with OSAHS in the primary care
setting.
At the end of the training period, all doctors (primary care physicians
and sleep specialists) analyzed 10 simulated cases of OSAHS with different
levels of severity and registers with technical errors. The degree of
agreement between each participating center (6 primary health-care
centers, 4 sleep units) and the coordinating sleep unit that selected the
simulation cases is shown in Table 2. The degree of agreement ranges from
moderate (Cohen’s kappa coefficient [κ] 0.47) to perfect agreement (κ=
1.0). Concordance was higher in examples of extreme cases (OSAHS clearly
present or clearly absent), whereas there was a greater variability in
decision-making for cases with suspicion of mild-to-moderate OSAHS.
Finally, therapeutic decisions simulation cases were reviewed in a
subsequent joint meeting of all study participants.
Study variables and data collection
The following variables will be collected: anthropometric (weight, height,
body mass index) and sociodemographic (age, sex) data; history of
cardiovascular diseases and cardiovascular risk factors; other comorbidities,
including cerebrovascular, metabolic, neurologic, respiratory, and psychia-
tric diseases; and pharmacological treatment. Clinical history directed to
assessment of sleep breathing disorders, including a specific clinical
questionnaire of suggestive symptoms of OSAHS, the Berlin question-
naire,33 the STOP-Bang sleep apnea questionnaire,34 and daytime
sleepiness using the Epworth sleepiness scale.35 Other studies include
forced spirometry36 and conventional polysomnography/respiratory poly-
graphy37,38 recording the following data: apnea–hypopnea index (AHI),
obstructive apnea index (episodes/h), hypopnea index (episodes/h),
central apnea index (episodes/h), mixed apnea index (episodes/h), mean
peripheral oxygen saturation (SpO2), time spent at SaO2 < 90% (CT90), falls
in SpO2 ≥ 3% (oxygen desaturation index [ODI]-3%) and ≥ 4% (ODI-4%) per
hour of recording, and time spent in the supine position.
The ambulatory monitoring sleep study will be carried out at the
patient’s home using a Bitmed Sleep&Go polygraph (Sibelmed, Barcelona,
Spain). The reference primary care nurse will be in charge of the analysis of
sleep quality, discarding the periods of deficient signal but will not analyze
all the events manually. The minimal valid recording time is defined as 5 h.
Polygraphy may be repeated if a poor signal acquisition is detected or the
patient reports poor sleep quality on the night of the study. The following
variables will be recorded: mean SpO2, ODI-3%, ODI-4%, AHI (cut-off points
5–15 for mild OSAHS, >15–<30 for moderate OSAHS, and ≥30 for severe
OSAHS), and percentage of time in supine position.
A file transfer protocol (FTP) has been developed for transmitting sleep
recorded data from primary care centers to the corresponding reference
sleep units. The FileZilla® software (version 3.3.0.1 - GNU General Public
License, version 2, June 1991, Free Software Foundation Inc.) is the server
that supports FTP. The program has been installed in each participating
center. A username and password was created for each research team,
giving access to its folder only. Primary care teams can only upload files to
their folders, whereas physicians from the sleep units can only download
files from primary care centers of their reference area. The coordinating
center has full access to folders of all participating centers in order to
review and solve any possible incidents that may happen. All patients’ data
will be anonymized.
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Model design and validation protocols
In all patients who fulfilled the inclusion criteria (Table 1), data on
anthropometric variables, clinical variables, and specific study question-
naires (Berlin questionnaire, STOP-Bang sleep apnea questionnaire, and
Epworth sleepiness scale) will be collected at the primary care setting.
Patients with a high probability of OSAHS according to results of the Berlin
questionnaire and 1 out of 3 patients with a low probability of OSAHS will
undergo the ambulatory monitoring sleep study and will be referred to the
sleep unit for completion of OSAHS evaluation. The selection of 1 out of 3
patients with low probability of OSAHS is established in order to balance
the study sample and tries to achieve a similar final proportion of patients
with high and low probability of OSAHS, taking into account that the
expected OSAHS population is approximately 30%.
On the basis of clinical data and results of ambulatory sleep study, the
primary care physician will take a clinical decision according to the
following four diagnostic–therapeutic scenarios: (a) low suspicion of
OSAHS and no need of treatment; (b) mild/moderate suspicion of OSAHS
and conservative treatment; (c) suspicion of OSAHS and candidate for
CPAP treatment; and (d) indeterminate in the presence of low quality of
ambulatory sleep study recording or discrepancy between clinical data and
results of ambulatory sleep study.
All patients undergoing home sleep monitoring independently of the high
or low initial clinical probability of OSAHS will be referred to the sleep unit,
where specialists, in a blinded fashion regarding primary care results and with
all documentation available, will take a further diagnostic–therapeutic
decision according to the same four possible scenarios defined in primary
care. Finally, all patients referred to the sleep unit will undergo a complete
respiratory polygraphy or conventional polysomnography at the sleep unit to
establish a definite diagnosis and therapeutic indication. This approach will
allow analyzing the diagnostic and therapeutic concordance between primary
care and specialized care, using the same basic tools (clinical findings and
ambulatory sleep monitoring) and with the final results of the gold standard
examination. The two stages of the model are shown in Figs 1 and 2.
Sample size calculation
The sample size has been calculated considering a minimal prevalence of
OSAHS of 25% in the population attended in the primary care setting.
Assuming a loss of 15% at follow-up, an alpha error of 5%, and a 90%
statistical power, a total sample of 198 patients would be required for 90%
sensitivity in the validation sample (99 patients in each arm with low/high
probability of OSAHS). However, the number of valid initial questionnaires
should be much higher, given that all patients with a priori high probability
of OSAHS and 1:3 of those with low probability will be included. In this
way, it is intended to adjust the performance of sleep studies and the
balance between OSAHS subjects/non-OSAHS subjects. Therefore, a
minimum number of 396 valid questionnaires are planned.
Statistical analysis
Categorical variables will be expressed as frequencies and percentages and
quantitative variables as mean and standard deviation (SD), median and
interquartile range (25th–75th percentile), and 95% confidence interval
(CI). Bivariate analysis will include chi-square (χ2) test or Fisher’s exact
probability test for categorical data and Student’s t test or Mann–Whitney
U test for continuous data according to the conditions of application. The
degree of agreement between the participating centers regarding ten
simulated cases has been analyzed with the Cohen’s kappa correlation
coefficient (Table 2). The clinical prediction model will be based on logistic
Table 1. Inclusion/exclusion criteria
Inclusion criteria Exclusion criteria
• Men and women • Cognitive impairment or psychosocial inability to perform
the ambulatory sleep study
• Age ≥18 and ≤75 years • Unstable or acute cardiovascular or cerebrovascular disease
• Patients visited at the participating primary care centers for any reason will be
consecutively included according to a randomization schedule to reach the
necessary sample size
• Chronic insomnia (<5 h of sleep/day)
• Previous diagnosis of OSAHS
• Relevant respiratory comorbidity that may interfere with
arterial blood saturation measurements
• Moderate-to-severe COPD (FEV1/FVC < 0.7%, FEV1 < 50%
predicted)
• History of neuromuscular disease
• Patient’s refusal to participate in the study
OSAHS obstructive sleep apnea hypopnea syndrome, COPD chronic obstructive pulmonary disease, FEV1 forced expiratory volume in one second, FVC forced
vital capacity
Table 2. Agreement between each participating center and the coordinating center
Participating center Cohen’s kappa (κ) Asymptotic standard errora Approx. Tb Approx. Sig.
Sleep unit #2 0.571 0.182 3.086 0.002
Sleep unit #3 1.0 0.0 5.331 0.000
Sleep unit #4 0.865 0.128 4.749 0.000
Primary care center #1 0.474 0.182 2.868 0.004
Primary care center #2 0.595 0.173 3.505 0.000
Primary care center #3 0.571 0.173 3.203 0.001
Primary care center #4 0.861 0.127 4.642 0.000
Primary care center #5 0.595 0.173 3.505 0.000
Primary care center #6 0.459 0.185 2.642 0.008
Coordinating center: sleep unit #1
aNot assuming the null hypothesis
bUsing the asymptomatic standard error assuming the null hypothesis
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regression analysis. All variables statistically significant in the bivariate
analysis and those considered to be clinically relevant will be included in
the logistic regression model. Hosmer–Lemeshow goodness-of-fit test and
the area under the receiver operating characteristics curve will be used to
validate the model. Statistical significance is set a P < 0.05 (two tailed). Cost
analysis will be performed from the Spanish Health System perspective
using a bottom–up costing approach. Direct costs of tests (ambulatory
sleep monitoring study, polygraphy, polysomnography), personnel,
amortization of equipments, transfer of patients, and number of visits will
be considered. For the cost-effectiveness analysis, false positive and false
positive cases of the coordinated strategy versus conventional manage-
ment will be considered. A Markov model will be constructed following the
methodology proposed by Pietzsch et al.39 in which, with a time horizon of
10 years, the effect of treatment of OSAHS will be considered according to
data collected from the literature on health-related quality of life,
cardiovascular comorbidity, and risk of traffic accidentability.
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